Air versus Saline in Initial Prepectoral Tissue Expansion: A Comparison of Complications and Perioperative Patient-Reported Outcomes.

Plastic and reconstructive surgery 2023 Vol.152(4S) p. 25S-34S

Plotsker EL, Coriddi MR, Rubenstein RN, Chu JJ, Haglich K, Disa JJ, Matros E, Dayan JH, Allen RJ, Nelson JA

관련 도메인

Abstract

[BACKGROUND] One option to optimize prepectoral tissue expander fill volume while minimizing stress on mastectomy skin flaps is to use air as an initial fill medium, with subsequent exchange to saline during postoperative expansion. The authors compared complications and early patient-reported outcomes (PROs) based on fill type in prepectoral breast reconstruction patients.

[METHODS] Prepectoral breast reconstruction patients who underwent intraoperative tissue expansion with air or saline from 2018 to 2020 were reviewed to assess fill-type utilization. The primary endpoint was expander loss; secondary endpoints included seroma, hematoma, infection/cellulitis, full-thickness mastectomy skin flap necrosis requiring revision, expander exposure, and capsular contracture. PROs were assessed with the BREAST-Q Physical Well-Being of the Chest scale 2 weeks postoperatively. Propensity-matching was performed as a secondary analysis.

[RESULTS] Of 560 patients (928 expanders) included in the analysis, 372 had devices initially filled with air (623 expanders), and 188 with saline (305 expanders). No differences were observed for overall rates of expander loss (4.7% versus 3.0%, P = 0.290) or overall complications (22.5% versus 17.7%, P = 0.103). No difference in BREAST-Q scores was observed ( P = 0.142). Utilization of air-filled expanders decreased substantially over the last study year. After propensity matching, no differences in loss, other complications, or PROs were observed across cohorts.

[CONCLUSIONS] Tissue expanders initially filled with air seem to have no significant advantage over saline-filled expanders in maintaining mastectomy skin flap viability or PROs, including after propensity matching. These findings can help guide choice of initial tissue expander fill type.

[CLINICAL QUESTION/LEVEL OF EVIDENCE] Therapeutic, III.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 4
시술 flap 피판재건술 dict 2
해부 Prepectoral Tissue scispacy 1
해부 prepectoral tissue expander scispacy 1
해부 tissue scispacy 1
합병증 prepectoral breast scispacy 1
합병증 full-thickness mastectomy scispacy 1
합병증 expanders scispacy 1
합병증 hematoma 혈종 dict 1
합병증 seroma 장액종 dict 1
합병증 infection 감염 dict 1
합병증 cellulitis 감염 dict 1
합병증 flap necrosis 괴사 dict 1
합병증 capsular contracture 피막구축 dict 1
약물 Saline scispacy 1
약물 [BACKGROUND] One scispacy 1
약물 [CONCLUSIONS] Tissue expanders scispacy 1
질환 Prepectoral breast scispacy 1
질환 expander loss scispacy 1
질환 necrosis C0027540
Necrosis
scispacy 1
기타 skin flaps scispacy 1
기타 patients scispacy 1
기타 skin flap scispacy 1
기타 capsular scispacy 1
기타 PROs → patient-reported outcomes scispacy 1
기타 tissue expander scispacy 1

MeSH Terms

Humans; Female; Mastectomy; Mammaplasty; Breast Neoplasms; Retrospective Studies; Tissue Expansion; Tissue Expansion Devices; Postoperative Complications; Breast Implants

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문